MedTrace Logo

Neuro-COVID-19: Neurological Complications of COVID-19

NCT04418609 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 8

Last updated 2022-08-04

No results posted yet for this study

Summary

The prevalence and typical patterns of neurological complications in hospitalized COVID-19 patients admitted to the intensive care units of the University Hospital Zurich will be investigated. The impact of neurological complications among COVID-19 patients on mortality, functional outcome, and organizational outcomes will be analyzed.

Conditions

  • Neurologic Complication

Interventions

OTHER

further processing of health data

further processing of biological materials and health related personal data for research

Sponsors & Collaborators

  • Emanuela Keller

    lead OTHER

Principal Investigators

  • Emanuela Keller, Prof. Dr. · University Hospital, Zürich

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-01
Primary Completion
2022-06-09
Completion
2022-06-09

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04418609 on ClinicalTrials.gov